153 related articles for article (PubMed ID: 31816339)
1. Oral repeated-dose toxicity studies of BIA 10-2474 in cynomolgus monkeys.
Weber K; Häcker R; Hardisty JF; Harris SB; Hayes AW
Regul Toxicol Pharmacol; 2020 Mar; 111():104547. PubMed ID: 31816339
[TBL] [Abstract][Full Text] [Related]
2. Oral repeated-dose toxicity studies of BIA 10-2474 in Wistar rat.
Hayes AW; Hardisty JF; Harris SB; Okazaki Y; Weber K
Regul Toxicol Pharmacol; 2020 Mar; 111():104540. PubMed ID: 31759138
[TBL] [Abstract][Full Text] [Related]
3. Oral repeated-dose toxicity studies of BIA 10-2474 in beagle dogs.
Hardisty JF; Harris SB; Hayes WA; Weber K
Regul Toxicol Pharmacol; 2020 Mar; 111():104555. PubMed ID: 31874201
[TBL] [Abstract][Full Text] [Related]
4. Oral repeated-dose toxicity studies of BIA 10-2474 in CD-1 mice.
Hayes AW; Pressman P; Hardisty JF; Harris SB; Weber K
Regul Toxicol Pharmacol; 2020 Mar; 111():104557. PubMed ID: 31866343
[TBL] [Abstract][Full Text] [Related]
5. Developmental and reproductive toxicity studies of BIA 10-2474.
Harris SB; Hardisty JF; Hayes AW; Weber K
Regul Toxicol Pharmacol; 2020 Mar; 111():104543. PubMed ID: 31759137
[TBL] [Abstract][Full Text] [Related]
6. Non-clinical toxicology evaluation of BIA 10-2474.
Hayes AW; Weber K; Moser P; Soares-da-Silva P
Crit Rev Toxicol; 2021 Jan; 51(1):65-75. PubMed ID: 33528291
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
9. Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10-2474: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Volunteers.
Rocha JF; Santos A; Gama H; Moser P; Falcão A; Pressman P; Wallace Hayes A; Soares-da-Silva P
Clin Pharmacol Ther; 2022 Feb; 111(2):391-403. PubMed ID: 33998672
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide Hydrolase.
Kiss LE; Beliaev A; Ferreira HS; Rosa CP; Bonifácio MJ; Loureiro AI; Pires NM; Palma PN; Soares-da-Silva P
ChemMedChem; 2018 Oct; 13(20):2177-2188. PubMed ID: 30113139
[TBL] [Abstract][Full Text] [Related]
11. Regulatory safety pharmacology evaluation of BIA 10-2474.
Hayes AW; Pressman P; Moser P; Soares-da-Silva P
J Pharmacol Toxicol Methods; 2020; 102():106677. PubMed ID: 31978535
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Promethazine Hydrochloride (CAS No. 58-33-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Dec; 425():1-272. PubMed ID: 12616286
[TBL] [Abstract][Full Text] [Related]
13. Neurotoxic effects of the anti-varicella zoster virus agent 2'-valeryl-6-methoxypurine arabinoside in monkeys and rats dosed orally for 90 days.
Szczech GM; Tucker WE
Fundam Appl Toxicol; 1992 Feb; 18(2):314-20. PubMed ID: 1318240
[TBL] [Abstract][Full Text] [Related]
14. Repeat oral dose toxicity studies of melamine in rats and monkeys.
Early RJ; Yu H; Mu XP; Xu H; Guo L; Kong Q; Zhou J; He B; Yang X; Huang H; Hu E; Jiang Y
Arch Toxicol; 2013 Mar; 87(3):517-27. PubMed ID: 23052191
[TBL] [Abstract][Full Text] [Related]
15. The absence of genotoxicity of a novel fatty acid amide hydrolase inhibitor, BIA 10-2474.
Hayes AW; Hardisty JF; Harris SB; Weber K
Regul Toxicol Pharmacol; 2020 Mar; 111():104556. PubMed ID: 31866344
[TBL] [Abstract][Full Text] [Related]
16. Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase.
Kerbrat A; Ferré JC; Fillatre P; Ronzière T; Vannier S; Carsin-Nicol B; Lavoué S; Vérin M; Gauvrit JY; Le Tulzo Y; Edan G
N Engl J Med; 2016 Nov; 375(18):1717-1725. PubMed ID: 27806235
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Benzyl Acetate (CAS No. 140-11-4) in F344/N Rats and B6C3F1 Mice Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 431():1-285. PubMed ID: 12616300
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of N-Methylolacrylamide (CAS No. 924-42-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 Sep; 352():1-204. PubMed ID: 12704432
[TBL] [Abstract][Full Text] [Related]
19. [An oral repeated dose toxicity study of a new antineoplastic agent S-1 in dogs. I. A 13-week repeated dose toxicity study. II. An ophthalmologic toxicity recovery study].
Hayashi T; Yamaguchi S; Kito S; Tanaka G; Kurokawa K; Hirota T
J Toxicol Sci; 1996 Nov; 21 Suppl 3():527-44. PubMed ID: 9021660
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
